Working towards the development of an evolvable cancer treatment simulator, the investigation of Differential Evolution was considered, motivated by the high efficiency of variations of this technique in real-valued problems. A basic DE algorithm, namely "DE/rand/1" was used to optimize the simulated design of a targeted drug delivery system for tumor treatment on PhysiCell simulator. The suggested approach proved to be more efficient than a standard genetic algorithm, which was not able to escape local minima after a predefined number of generations. The key attribute of DE that enables it to outperform standard EAs, is the fact that it keeps the diversity of the population high, throughout all the generations. This work will be incorporated with ongoing research in a more wide applicability platform that will design, develop and evaluate targeted drug delivery systems aiming cancer tumours.
Introduction
Differential evolution (DE) gained popularity over other well-established evolutionary algorithms (EAs), as it follows similar algorithmic steps with standard EAs, but was able to surpass them in terms of efficiency [1] . There have been several proposals on how to enhance its performance [2, 3] and these alternative algorithmic approaches, building on the initial methodology, were tested in real problems , as well as numerical benchmark problems [4, 5, 6, 7] .
DE was initially proposed in [1] , as an effective methodology of optimization over continuous spaces of nonlinear and non differentiable functions. The method was introduced as an alternative to previous direct search approaches, aiming at three main objectives: the ability to find the global optimum, the fast convergence to this optimum and the need of a small amount of control parameters for the procedure. Moreover, it was developed to be easily implemented in parallel computing platforms. The methodology is population based, where for every generation the new individuals are produced after applying the scaled difference (hence the name differential evolution) of some predefined individuals to another predefined base individual.
The ability to easily extract attributes of the population, such as the distance of its members and their directions, through the aforementioned methodology, is what makes DE so powerful. This characteristic is defined as self-referential arXiv:2003.11623v1 [cs.NE] 21 Mar 2020 mutation [8] . Given the aforementioned advantages of DE compared with other EAs, it was chosen to investigate the optimization of a targeted drug delivery system (DDS) on a cancer tumour, when simulated with PhysiCell [9] .
PhysiCell [9] is a multicellular, agent-based simulator that was designed to extend the BioFVM [10] framework, to form a virtual laboratory. PhysiCell is open source and offers several sample projects, one of which is the one studied in this study. More specifically, sample project "anti-cancer biorobots" [9] was developed as a possible tool to investigate the targeted cancer treatment, i.e. with drugs transported by specialized nanoparticles that would target specific cells of the cancer tumours.
Previously, PhysiCell was deployed as a virtual laboratory in the optimization process of the design of nanoparticle carriers of cancer treating compounds [11, 12] and the process of mapping immunotherapies [13] . More specifically, the use of PhysiCell led the training of surrogate-assisted evolutionary algorithms exploring the efficient solutions of the design of nanoparticle-based drug delivery systems for cancer [11] . A similar application of PhysiCell was examined in [12] , where the optimization was achieved by a novel memetic algorithm inspired by the fundamental haploid-diploid lifecycle of eukaryotic organisms [14, 15] . A similar application is considered here, however the exploration of the solution space is investigated through DE. Moreover, active learning and genetic algorithms incorporated with the PhysiCell simulator, enabled the efficient exploration of biological and clinical constraints for cancer immunotherapy [13] .
Differential evolution
The methodology of DE comprises of the following steps: initialization, mutation, recombination (or crossover) and selection. At first, a population of individuals (possible solutions) is formed by randomly picking values on the D-dimensional search space of the problem to be optimized. The random function used is mainly uniformly distributed to cover sufficiently the search space, which could be limited with lower and upper boundaries depending on the definition of the problem.
Then, the mutation operator is employed on the initial population. More specifically, for every individual in the population a new individual is generated (named the mutant individual) by a mathematical expression of the parameters of randomly chosen or predefined individuals. For example, the mutant individual (v i ) can be the linear combination of three randomly selected individuals as defined by the following equation, where x r1 , x r2 and x r3 are randomly selected individuals from the population and F is a scaling factor, which is a positive number.
Note here, that the variations of DE methodology are defined with a notation in the form of "DE/base/num". The "base" part of the notation refers to the technique of choosing the individual that will be used as the base individual to which the scaled difference will be added. The "num" part indicates the amount of pairs of individuals that will produce a scaled difference each, to be added on the base individual. Thus, the aforementioned DE variation is denoted as "DE/rand/1".
The produced mutant individuals, then, undergo the crossover operator, in order to be recombined with individuals from the initial population. Each individual chosen from the initial population is denoted as the target individual and the produced individual after the crossover as the trial individual. Two crossover strategies are mainly used, namely exponential and binomial. However, binomial is dominant in the literature, where every parameter in the D-dimensional solution is treated separately to the others, and chosen from the mutant or the target individual based on a probability defined as the CR parameter. This parameter is known as the crossover rate.
The final step of the algorithm is then evaluation, by the use of the selection operator. Similar to standard GAs, the trial individuals produced from the previous step, are evaluated with the fitness function. If their fitness is better than the one of their target individual, they replace the target individual in the next generation. Otherwise the target individual is retained. When all trial individuals are tested and the appropriate selection is made to form the population of the next generation, the algorithm runs again the population through the mutation, crossover and selection operators, until the termination criteria are met (i.e. the computation budget).
Methodology
The sample project from PhysiCell framework that was investigated, is the "anti-cancer biorobots". In this simulation all entities are simulated as agents. Namely, there are three different types of agents with different functionalities, the cancer cells, the chemical compound (defined as cargo agents) and the functionalized nanoparticles (defined as worker agents). The outputs of PhysiCell include graphical representation of the agents in the simulated areas. An example For comparison reasons, a generic GA was applied to optimize the aforementioned problem. The parameters of the GA were chosen as population size P = 20, tournament size T = 2 for selection and replacement operations, uniform crossover with probability X = 80% and per allele mutation rate of µ = 20% with random step size of s = [−5, 5]%.
On the other hand, the "DE/rand/1" strategy was implemented and tested for the optimization of a targeted DDS on a cancer tumour, by simulating this procedure with PhysiCell. The parameters of the DE algorithm were chosen as population size P = 20, scaling factor F = 0.5 and crossover rate CR = 0.9. Note that these parameters are not fine-tuned to enhance the performance of the algorithm, but are most commonly used throughout the literature.
The rest of the parameters used to define the simulation of the tumour environment by PhysiCell were retained unchanged. More specifically these parameters are listed in Table 1 .
Results
Three comparison tests were run, each using the same initial population for the GA and DE optimization. The results of the average fitness (remaining cancer cells after 10 days of simulation) of all individuals of the population through out the generations are depicted in Figs. 2 -4(a) . Furthermore, the fitness of the best individual for both GA and DE throughout the generations was illustrated in Figs. 2 -4(b).
In Fig. 2(a) it is apparent that both approaches force the population to converge towards a lower fitness. However, in Fig.  2(b) the fact that DE outperforms the GA in finding better solutions from the first few generations is shown. Moreover, the GA seems to be stuck from the sixth generation in a local minimum.
In Fig. 3 (a) the GA approach seems to converge the average fitness of the population of solutions towards a lower fitness faster than the DE. Also, in Fig. 3(b) the DE approach is outperformed by GA for the first six generations. On the contrary, the GA is again stuck in a local optimum, while the DE is continuously evolving towards better solutions and manages to find a better one at the sixth generation.
Finally, the results from the third comparison run are presented in Fig. 4 . As in the previous runs, it can be claimed that DE outperforms the GA. Specifically, in Fig. 4(b) the DE approach reaches a fittest individual than GA at the very first generations. Furthermore, whereas the DE seems to be stuck in a local minimum from the third generation and the GA reaches a solution quite similar to this one, on the last generation the DE manages to escape its minimum and provide an ever better solution. The scatter plots of the parameters investigated during the evolution of DE in the third comparison run are outlined in Fig. 5 . It is clear that the individuals produced with the DE approach cover the search space better than the ones produced by GA (illustrated in Fig. 6 ). This is attributed to the fact that DE is designed to tackle models defined in Figure 6 : Scatter plot of all individuals tested during the GA approach for the third run. The red "X" mark denotes the best individual found.
real-values search spaces, whereas GA is not. As a result, the GA is heavily limited by the randomly produced initial population, a disadvantage that is alleviated by the DE methodology. In addition, to clearly portray the reason why GA is easily trapped in local optima, while DE manages to escape them, Figs. 7 and 8 are given, that present the final population of the DE and GA approaches for the third run, respectively. The DE approach succeeds in maintaining a high diversity in the final population as shown in Fig. 7 , where no duplicate individuals can be spotted. On the other hand, in Fig. 8 the final population of the GA approach is apparently comprised by multiple copies of just two individuals, which are also very close to each other. Consequently, the GA can not escape from these two individuals unless a dramatic mutation happens (not possible as the mutation step size was set here to s = [−5, 5]%).
Conclusion
The optimization of the design of targeted DDS on a cancer tumor, simulated by PhysiCell, was studied by utilizing "DE/rand/1" approach. The DE approach was compared with a standard steady state GA with the same computation budget, namely 1000 evaluations. The results derived from the comparison runs of both approaches equipped with the same initial population unveiled that DE is a more robust algorithm to reach a better solution within the same amount of generations. On top of that, DE enables the further exploration of the search space as it maintains a high diversity of the individuals in the final population.
As an aspect of future work, different variations of DE can be investigated with PhysiCell and under alternative ultimate goals, for instance the ability of niching is well documented in variants of DE [16] . Finally, the conclusions driven from this study will be applied on ongoing research towards a more wide applicability platform that will design, develop and evaluate DDSs aiming cancer tumours.
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